Therapeutic Asset Ratings

6,308 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Zelenectide Pavedotin Urinary Bladder Neoplasm	BicycleTx Limited	P1/2	CCC (48)
Zeprumetostat Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma	Sun Yat-sen University	P1/2	CCC (48)
Ziftomenib Cancer	Kura Oncology, Inc.	P1/2	CCC (48)
Ziftomenib Mixed Phenotype Acute Leukemia	Kura Oncology, Inc.	P1/2	CCC (48)
Zimberelimab Pancreatic Adenosquamous Carcinoma	James Cleary, MD, PhD	P1/2	CCC (48)
Zimberelimab Breast Cancer	H. Lee Moffitt Cancer Center and Research Institute	P1/2	CCC (48)
Zimberelimab Squamous Cell Carcinoma Of Pancreas	James Cleary, MD, PhD	P1/2	CCC (48)
Zirconium Zr 89 Crefmirlimab Berdoxam Urinary Bladder Neoplasm	AstraZeneca	P1/2	CCC (48)
Zn-A-1041 Cancer	Suzhou Zanrong Pharma Limited	P1/2	CCC (48)
Zoledronate Chordoma	University of Florida	P1/2	CCC (48)
Zoledronate Clear Cell Sarcoma	University of Florida	P1/2	CCC (48)
Zoledronate Desmoplastic Small Round Cell Tumor	University of Florida	P1/2	CCC (48)
Zoledronate Epithelioid Sarcoma	University of Florida	P1/2	CCC (48)
Zoledronate Myoepithelial Tumor	University of Florida	P1/2	CCC (48)
Zoledronate Nerve Sheath Neoplasm	University of Florida	P1/2	CCC (48)
Zoledronate Rhabdoid Tumor	University of Florida	P1/2	CCC (48)
Zoledronate Rhabdomyosarcoma	University of Florida	P1/2	CCC (48)
Zunsemetinib Breast Carcinoma	Washington University School of Medicine	P1/2	CCC (48)
Β-Globin Restored Autologous Hsc Beta-Thalassemia Major	Bioray Laboratories	P1/2	CCC (48)
1.0% ip-001 for Non-Small Cell Lung Carcinoma	Immunophotonics, Inc.	P1/2	CC (47)
[111in]-fpi-1967 Urinary Bladder Carcinoma	Fusion Pharmaceuticals Inc.	P1/2	CC (47)
1-(4,4-BIS(P-FLUOROPHENYL)BUTYL)-4-(4-CHLORO-.ALPHA.,.ALPHA.,.ALPHA.-TRIFLUORO-M-TOLYL)-4-PIPERIDINOL Small Cell Carcinoma	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	P1/2	CC (47)
177lu-betabart Castration-Resistant Prostate Carcinoma	Radiopharm Theranostics, Ltd	P1/2	CC (47)
177lu-betabart Triple-Negative Breast Carcinoma	Radiopharm Theranostics, Ltd	P1/2	CC (47)
177lu htk03170 Castration-Resistant Prostate Carcinoma	British Columbia Cancer Agency	P1/2	CC (47)

Showing 2051 to 2075 of 6,308 assets

PreviousPage 83 of 253Next